Experiences of Healthcare Professionals Working in Injectable Opioid Agonist Treatment Programs: A Qualitative Thematic Analysis
Gadimova, F; Jackson, J., Journal of Addictions Nursing
Acceptability of long-acting antiretroviral therapy among people living with HIV who use drugs in Vancouver, Canada: A qualitative study
Chayama KL, Ng C, Brohman I, Mansoor M, Small W, Philbin M, Collins AB, McNeil R., PLoS One. 2025
Cannabis use and illicit opioid cessation among people who use drugs living with chronic pain
Kitchen C, Socías ME, Sayre EC, Hayashi K, DeBeck K, Milloy MJ, Kerr T, Reddon H, Drug Alcohol Rev
Using illicit drugs alone in Vancouver, Canada: a gender-based analysis
Gallant K, Hayashi K, Sayre EC, Choi J, Mansoor M, Kerr T., Subst Abuse Treat Prev Policy. 2025
Building social support into mental health and substance use treatment trajectories: Insights from a longitudinal qualitative and ethnographic study with young people experiencing unstable housing and homelessness
Lee H, Thulien M, Eekhoudt CR, Friesen D, Manson D, Bagley S, Hadland S, Fast D., Child Youth Serv. 2025
“We need all hands on deck”: characterizing addiction medicine training in Canada-a mixed methods study of fellowship program directors
Lu C, Chan K, Martin L, Fairbairn N., Addict Sci Clin Pract. 2025
‘It just doesn’t stop’: Perspectives of women who use drugs on increased overdoses during the COVID-19 pandemic
Patterns of socioeconomic marginalization and non-fatal overdose among people who use drugs: A gender-stratified repeated measures latent class analysis
Mitra S, Richardson L, Cui Z, Gilbert M, Milloy MJ, Hayashi K, Kerr T., Soc Sci Med. 2025
Technology-Based Psychotherapeutic Interventions for Decreasing Cannabis Use in People with Psychosis: A Systematic Review Update
Tatar O, Bakouni H, Abdel-Baki A, Jutras-Aswad D., Cannabis Cannabinoid Res. 2025
Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study
Bouthillier A, Bastien G, McAnulty C, Bakouni H, Le Foll B, Socias ME, Jutras-Aswad D., Harm Reduct J. 2025
